Pill Identifier App

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

More U.S. Newborns Enduring Drug Withdrawal: Study

The number of U.S. infants admitted to neonatal intensive care units to treat symptoms of drug withdrawal has nearly quadrupled since 2004, researchers report. Neonatal abstinence syndrome -- a drug-withdrawal syndrome that often occurs after exposure to prescription narcotic painkillers during pregnancy -- affected only seven babies for every 1,000...

Posted today in Medical

Health Tip: Needing Folic Acid

-- Among the health benefits of folic acid is that it can help prevent birth defects in a growing fetus. But pregnant women aren't the only people who should take it. The Womenshealth.gov website says these people may benefit from folic acid: Women who are pregnant or who want to become pregnant, or breast-feeding mothers. Women who have given birth...

Posted 2 days ago in New Drug Approvals

FDA Approves Cyramza (Ramucirumab) for Use with FOLFIRI in Second-Line Treatment of Metastatic Colorectal Cancer

Eli Lilly and Company (NYSE: LLY) has received its fourth U.S. Food and Drug Administration (FDA) approval for Cyramza (ramucirumab). Cyramza (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal...

Posted 3 days ago in New Drug Approvals

Medicure Announces Approval of Expanded Dosing Time For Aggrastat

WINNIPEG, April 23, 2015 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, is pleased to announce that the United States Food and Drug Administration (FDA) has approved a revision to the duration of the bolus delivery for the Aggrastat (tirofiban HCl) high-dose bolus (HDB) regimen. The...

Posted 3 days ago in FDA Alerts

Injectable Products by Mylan: Recall - Presence of Particulate Matter

including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot numbers affected by this recall. Some products may be packaged with a Pfizer Injectables label (see Background below)   [Posted 04/24/2015] ISSUE:...

Posted today in Medical

Health Tip: Smoking Affects Your Heart

-- Smoking can lead to cell and tissue damage throughout your body, and experts say your heart isn't spared. The U.S. National Heart Lung and Blood Institute says smoking can: Decrease the blood's ability to carry oxygen. Force the heart to work harder by raising blood pressure and heart rate. Raise triglycerides (fat) and bad cholesterol, while lowering...

Posted today in Medical

Pediatricians Issue New Guidelines for Hospital Release of Newborns

The American Academy of Pediatrics (AAP) has just released updated guidelines for judging whether or not a newborn is ready to leave the hospital. The decision to allow a healthy newborn to go home is made after careful review by health providers, but there can be wide variation in the degree of an infant's readiness to leave the hospital, and a number...

Posted today in Medical

Doctors Say Head Lice Should Not Bar Kids From School

Outbreaks of head lice in kids can be effectively treated without banning infected children from school, new guidelines from the American Academy of Pediatrics (AAP) say. In fact, the AAP believes that doctors and other health care professionals should educate schools and communities that "no-nit" policies are unfair and should not be implemented. Children...

Posted today in Medical

HPV Vaccine Produces Early Benefits for Teen Girls: Study

Girls as young as 14 are receiving important health benefits from the HPV vaccine, which protects against a sexually transmitted virus that causes cervical cancer, a new study reports. Canadian girls who received the vaccine around age 13 experienced a "large and significant reduction" in cases of cervical dysplasia -- an abnormal precancerous lesion...

Posted today in Medical

MRI May Help Gauge Stroke Risk in Those With Irregular Heartbeat

Special MRI scans of the heart can help spot people with atrial fibrillation -- a common heart rhythm disorder -- who are at high risk for stroke, a new study shows. The study also calls into question the mechanism linking atrial fibrillation with higher stroke risk, says a team reporting the findings April 27 in the Journal of the American Heart Association. The...

Read more news...

Recently added consumer and prescribing information: Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix, Natpara

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web1)